Study of M5049 in CLE and SLE Participants
Clinical trial NCT04647708 · COMPLETED
Trial details
- NCT number
- NCT04647708
- Sponsor
- Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2023-12-19
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.